查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1736534

非侵入性癌症診斷市場－依技術、設備、地區和預測的市場規模

Global Non-Invasive Cancer Diagnosis Market Size By Technology (Clinical Chemistry, Immunochemistry, Molecular Diagnostics), By Instruments (Solid Tumor, Blood Cancer, Lung Cancer, Breast Cancer), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 | 商品交期: 2-3個工作天內

價格
簡介目錄

非侵入性癌症診斷市場規模及預測

過去幾年，非侵入性癌症診斷市場規模一直以中等速度成長，成長率相當高，預計在市場估計和預測期內（即 2026 年至 2032 年）將大幅成長。

大規模都市化、居民消費能力的提升、對癌症診斷最新技術進步和趨勢的更多了解，以及非侵入性癌症診斷的優勢，將很快推動該市場的成長。 《非侵入性癌症診斷全球市場報告》對市場進行了全面評估，全面分析了關鍵細分市場、趨勢、市場促進因素、限制因素、競爭格局以及影響市場的關鍵因素。

定義全球非侵入性癌症診斷市場

非侵入性癌症診斷是使用無針診斷技術識別或測量癌症病變的過程。這種診斷方法涵蓋多種技術，例如生物標記、分子生物學變化、基因結構和其他成像技術。生物技術領域的發展推動了非侵入性癌症診斷技術的發展，可用於早期發現癌症。

全球非侵入性癌症診斷市場概況

推動市場成長的主要因素是非侵入性癌症診斷，這是一種透過體內微創手術識別癌症的方法。該過程通常包含多種技術，例如基因結構識別、生物標記識別、分子生物學改造、成像技術等。全球對精準微創診斷的需求不斷成長，以及醫療保健支出的不斷成長，是非侵入性癌症診斷的主要促進因素。

此外，非侵入性診斷需求的不斷成長促使政府加強改善醫療基礎設施，舉措計劃的增加也推動了市場的發展。然而，高昂的治療費用和嚴格的監管準則阻礙了市場的成長。快速的技術進步和設備創新預計將為市場帶來豐厚的機會。另一方面，新興國家尚未開發的需求也可能對市場成長構成挑戰。

目錄

第1章全球非侵入性癌症診斷市場簡介

  • 市場概覽
  • 研究範圍
  • 先決條件

第2章執行摘要

第3章：已驗證的市場研究調查方法

  • 資料探勘
  • 驗證
  • 第一手資料
  • 資料來源列表

第4章全球非侵入性癌症診斷市場展望

  • 概述
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 波特五力模型
  • 價值鏈分析

5. 全球非侵入性癌症診斷市場（按技術）

  • 概述
  • 臨床化學
  • 免疫化學
  • 分子診斷

6. 全球非侵入性癌症診斷市場（按設備）

  • 概述
  • 固體癌
  • 血癌
  • 肺癌
  • 乳癌

7. 全球非侵入性癌症診斷市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 世界其他地區
    • 拉丁美洲
    • 中東和非洲

8. 全球非侵入性癌症診斷市場的競爭格局

  • 概述
  • 各公司市場排名
  • 主要發展策略

第9章 公司簡介

  • Precision Therapeutics, Inc.
  • AVIVA Biosciences Corporation
  • Affymetrix Inc.
  • BIOVIEW Inc.
  • Gen-Probe Incorporated

第10章 附錄

  • 相關調查
簡介目錄
Product Code: 37637

Non-Invasive Cancer Diagnosis Market Size And Forecast

Non-Invasive Cancer Diagnosis Market size is growing at a moderate pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2026 to 2032.

Large-scale urbanization, an increase in the spending power of people, more awareness about the latest technological advancements and trends in cancer diagnosis, and the benefits of non-invasive cancer diagnosis will lead to the growth of this market shortly. The Global Non-Invasive Cancer Diagnosis Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Non-Invasive Cancer Diagnosis Market Definition

A non-Invasive cancer diagnosis is a process of identifying or measuring the cancer disease with a needle-free diagnosis technique. This diagnosis method comprises several techniques, including biomarkers, changes in molecular biology, genetic structure, and other imaging diagnosis techniques. Advancements in the biotechnology sector have enabled the development of non-invasive cancer diagnosis for the early detection of cancer.

Global Non-Invasive Cancer Diagnosis Market Overview

The primary factors driving the market growth are the non-invasive cancer diagnosis is a way to identify cancer problems with minimal incisions in the body. This process generally consists of various techniques such as gene structure identification, biomarkers, molecular biology modifications, and imaging techniques. The growing demand for accurate, minimally invasive diagnostics and growth in medical costs were observed across the globe as critical drivers.

In addition, increasing demand for non-invasive diagnostics increases government initiatives to improve medical infrastructure, and increased research and development projects drive market growth. However, high treatment costs and strict regulatory guidelines hamper market growth. Rapid technological advances and innovations in devices are expected to create beneficial opportunities for the market. On the other hand, the needs of untapped developing countries can challenge market growth.

Global Non-Invasive Cancer Diagnosis Market: Segmentation Analysis

The Global Non-Invasive Cancer Diagnosis Market is segmented on the basis of Technology, Instruments, And Geography.

Non-Invasive Cancer Diagnosis Market, By Technology

  • Clinical Chemistry
  • Immunochemistry
  • Molecular Diagnostics

Based on Technology, The market is bifurcated into Clinical Chemistry, Immunochemistry, and Molecular Diagnostics. The Clinical Chemistry segment holds a large number of shares in the market because of the availability of the clinical data for several cancer indications and increasing non-invasive diagnostic technology, which is the factor that boosts the market growth.

Non-Invasive Cancer Diagnosis Market, By Instruments

  • Solid Tumor
  • Blood Cancer
  • Lung Cancer
  • Breast Cancer

Based on Instruments, The market is bifurcated into Solid Tumor, Blood Cancer, Lung Cancer, and Breast Cancer. The Breast Cancer segment holds a large number of shares in the market because of the increasing number of cases across the globe and enhancing healthcare sector, which is the factor that boosts the market growth.

Non-Invasive Cancer Diagnosis Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Geography, The Global Non-Invasive Cancer Diagnosis Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The North American region holds a large number of shares in the market because of the increasing healthcare expenditure and rising research and development activities in the region. At the same time, Asia-Pacific is the fastest-growing region because of the rising number of patients with an increase in awareness regarding the minimal invasive equipment in the region, which is the factor that increased the market growth.

Key Players

The "Global Non-Invasive Cancer Diagnosis Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Precision Therapeutics Inc., AVIVA Biosciences Corporation, Affymetrix Inc., BIOVIEW Inc., Gen-Probe Incorporated, and many more. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL NON-INVASIVE CANCER DIAGNOSIS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL NON-INVASIVE CANCER DIAGNOSIS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL NON-INVASIVE CANCER DIAGNOSIS MARKET, BY TECHNOLOGY

  • 5.1 Overview
  • 5.2 Clinical Chemistry
  • 5.3 Immunochemistry
  • 5.4 Molecular Diagnostics

6 GLOBAL NON-INVASIVE CANCER DIAGNOSIS MARKET, BY INSTRUMENTS

  • 6.1 Overview
  • 6.2 Solid Tumor
  • 6.3 Blood Cancer
  • 6.4 Lung Cancer
  • 6.5 Breast Cancer

7 GLOBAL NON-INVASIVE CANCER DIAGNOSIS MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East And Africa

8 GLOBAL NON-INVASIVE CANCER DIAGNOSIS MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Precision Therapeutics, Inc.
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 AVIVA Biosciences Corporation
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Affymetrix Inc.
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 BIOVIEW Inc.
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Gen-Probe Incorporated
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments

10 Appendix

  • 10.1 Related Research